Efficacy and safety of repeated boluses of urokinase in the treatment of deep venous thrombosis
- 1 January 1994
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 73 (1) , 75-79
- https://doi.org/10.1016/0002-9149(94)90730-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trialJournal of the American College of Cardiology, 1992
- Predictive factors of effectiveness of streptokinase in deep venous thrombosisThe American Journal of Cardiology, 1992
- Prolonged bleeding time as a marker of venous clot lysis during streptokinase therapyAmerican Heart Journal, 1991
- Streptokinase therapy for deep vein thrombosis: A comprehensive review of the english literatureThe American Journal of Medicine, 1990
- Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosisThe American Journal of Medicine, 1990
- Streptokinase vs Heparin for Deep Venous ThrombosisArchives of internal medicine (1960), 1989
- Streptokinase vs heparin for deep venous thrombosis. Can lytic therapy be justified?Archives of internal medicine (1960), 1989
- Multicenter pilot study of the efficacy and safety of systemic rt-PA administration in the treatment of deep vein thrombosis of the lower extremities and/or pelvisThrombosis Research, 1989
- Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosisThe American Journal of Medicine, 1984
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957